Study on Epidemiology and Antibiotics Resistance of Pseudomonas Aeruginosa

SONG Zhi-xiang,XUE Wen-ying,HU Feng-jun,LI Yue,CHEN Liang
2011-01-01
Abstract:OBJECTIVE To investigate the epidemic situation,antibiotics resistance and treatment of Pseudomonas aeruginosa.METHODS P.aeruginosa isolated from the hospital from 2007 to 2009 were retrospectively analyzed according to specimen source,infection in different departments and drug-resistance.RESULTS The dection rate of P.aeruginosa was 23.63% during the three years,while the most common samples was sputum(92.56%).P.aeruginosa infection were found mostly in the department with senior patients,accounting for 31.23%,followed by the respiratory ward 25.01%.P.aeruginosa showed high-drug resistance and multi-drug resistance,P.aeruginosa showed the highest rate of resistance with more than 99.0% to ampicillin,ampicillin/sulbactam,cefazolin,cefoxitin,ceftriaxone,sulfamethoxazole compound.P.aeruginosa showed the lowest rate of resistance to amikacin and cefoperazone/sulbactam with 11.02% and 21.73%.ceftriaxone,cefotaxime,imipenem,levofloxacin resistant rate were more than 50.00%.Resistance rate to imipenem was 59.14%.imipenem-resistant acinetobacter show resistance to most of β-lactam antibiotics and quinolonos,we call this broad antibiotics-resistant acinetobacter.CONCLUSIONS P.aeruginosa is the most common bacteria in respiratory tract infection,treatment to P.aeruginosa is facing selection pressure because of broad antibiotics-resistant acinetobacter.cefoperazone /sulbactam and amikacin are the best choice for the experience treatment.It suggests that the clinicians should choose antibiotics rationally according to drug susceptibility test.
What problem does this paper attempt to address?